Table 1.
Basal characteristics from 25 patients with local recurrence and from 50 patients with distant metastasis, both as first manifestation after mastectomy, and from 50 patients without tumoral recurrence
| Characteristics | Patients without tumoral recurrence | Primary tumors of patients with local recurrence | Primary tumors of patients with distant metastasis |
|---|---|---|---|
| N (%) | N (%) | N (%) | |
| Total cases | 50 | 25 | 50 |
| Age (median) | |||
| ≤56 | 21 (42) | 13 (52) | 27 (54) |
| >56 | 29 (58) | 12 (48) | 23 (46) |
| Menopausal status | |||
| Premenopausal | 16 (32) | 9 (36) | 13 (26) |
| Postmenopausal | 34 (68) | 16 (64) | 37 (74) |
| T | |||
| T1–T2 | 28 (56) | 2 (8) | 21 (42) |
| T3–T4 | 22 (44) | 23 (92) | 29 (58) |
| Nodal status | |||
| Negative | 28 (56) | 12 (48) | 21 (42) |
| Positive | 22 (44) | 13 (52) | 29 (58) |
| SBR | |||
| I | 19 (38) | 2 (8) | 12 (24) |
| II | 24 (48) | 10 (40) | 25 (50) |
| III | 7 (14) | 7 (28) | 13 (26) |
| Unknown | 6 | ||
| RE | |||
| Negative | 15 (30) | 10 (40) | 32 (64) |
| Positive | 35 (70) | 15 (60) | 18 (36) |
| RP | |||
| Negative | 16 (32) | 13 (52) | 34 (68) |
| Positive | 34 (68) | 12 (48) | 16 (32) |
| Radiotherapy | |||
| No | 41 (82) | 8 (32) | 25 (50) |
| Yes | 9 (18) | 17 (68) | 25 (50) |
| Chemotherapy | |||
| No | 29 (58) | 9 (36) | 18 (36) |
| Yes | 21 (42) | 16 (64) | 32 (64) |
| Tamoxifen | |||
| No | 20 (40) | 6 (24) | 36 (72) |
| Yes | 30 (60) | 19 (76) | 14 (28) |